LCG
HCAT icon

Lisanti Capital Growth’s Health Catalyst HCAT Stock Holding History

Lisanti Capital Growth’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-67,590
Closed -$2.94M – 153
2020
Q4 		$2.94M Buy
+67,590
New +$2.49M 0.41% 87

Other funds holding HCAT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Riverbridge Partners
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Lisanti Capital Growth's HCAT Position: Q1 2021 in Review

Lisanti Capital Growth sold out of Health Catalyst (HCAT) in Q1 2021, closing a stake of 67,590 shares — an estimated $2.94M sold.

Lisanti Capital Growth first reported a position in HCAT in Q4 2020 and held it in 1 quarter. The position peaked at $2.94M in Q4 2020. 190 funds tracked by Wall St. Rank hold HCAT as of Q1 2021.

  • Lisanti Capital Growth reported no remaining Health Catalyst position as of Q1 2021 after selling out during the quarter.
  • Lisanti Capital Growth sold 67,590 Health Catalyst shares in Q1 2021, an estimated $2.94M.
  • Lisanti Capital Growth first reported a position in Health Catalyst in Q4 2020 and held it in 1 quarter.
  • Lisanti Capital Growth's Health Catalyst position peaked at $2.94M in Q4 2020.
  • 190 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2021.

Based on Lisanti Capital Growth's 13F filing for Q1 2021, filed 12 May 2021.